| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pro-Opiomelanocortin | 24 | 2023 | 90 | 6.510 |
Why?
|
| Neurons | 50 | 2024 | 1927 | 5.910 |
Why?
|
| Hypothalamus | 31 | 2024 | 216 | 4.990 |
Why?
|
| Energy Metabolism | 32 | 2022 | 765 | 4.990 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 11 | 2024 | 41 | 3.940 |
Why?
|
| Estrogens | 12 | 2020 | 507 | 3.630 |
Why?
|
| Serotonin | 14 | 2024 | 222 | 3.610 |
Why?
|
| Feeding Behavior | 18 | 2024 | 696 | 3.520 |
Why?
|
| Obesity | 40 | 2024 | 2227 | 3.290 |
Why?
|
| Eating | 17 | 2024 | 373 | 3.120 |
Why?
|
| Glucose | 20 | 2023 | 865 | 2.870 |
Why?
|
| Estrogen Receptor alpha | 10 | 2024 | 450 | 2.810 |
Why?
|
| Leptin | 18 | 2023 | 211 | 2.610 |
Why?
|
| Homeostasis | 24 | 2021 | 683 | 2.430 |
Why?
|
| Mice | 89 | 2024 | 17487 | 2.240 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 8 | 2021 | 44 | 2.160 |
Why?
|
| Agouti-Related Protein | 16 | 2023 | 42 | 2.140 |
Why?
|
| Animals | 108 | 2024 | 33723 | 1.990 |
Why?
|
| Melanocortins | 5 | 2023 | 12 | 1.900 |
Why?
|
| Receptors, Estrogen | 5 | 2017 | 789 | 1.670 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 7 | 2023 | 30 | 1.640 |
Why?
|
| Body Weight | 22 | 2023 | 999 | 1.540 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 11 | 2024 | 58 | 1.530 |
Why?
|
| Dopamine | 4 | 2023 | 275 | 1.530 |
Why?
|
| Mice, Transgenic | 23 | 2024 | 2390 | 1.510 |
Why?
|
| Mice, Inbred C57BL | 34 | 2024 | 4346 | 1.510 |
Why?
|
| Anorexia | 5 | 2023 | 28 | 1.480 |
Why?
|
| Neural Pathways | 9 | 2024 | 264 | 1.370 |
Why?
|
| Brain | 9 | 2021 | 2947 | 1.320 |
Why?
|
| Insulin Resistance | 15 | 2021 | 639 | 1.300 |
Why?
|
| Basal Forebrain | 3 | 2024 | 33 | 1.280 |
Why?
|
| Sex Characteristics | 3 | 2019 | 312 | 1.200 |
Why?
|
| Dorsal Raphe Nucleus | 3 | 2024 | 15 | 1.170 |
Why?
|
| Ventral Tegmental Area | 4 | 2023 | 50 | 1.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2020 | 340 | 1.100 |
Why?
|
| Bulimia | 3 | 2017 | 15 | 1.080 |
Why?
|
| Estradiol | 6 | 2024 | 534 | 1.050 |
Why?
|
| Hunger | 4 | 2021 | 50 | 1.030 |
Why?
|
| Blood Glucose | 10 | 2023 | 1114 | 0.980 |
Why?
|
| Mice, Knockout | 28 | 2024 | 3715 | 0.980 |
Why?
|
| Neuropeptide Y | 5 | 2016 | 36 | 0.930 |
Why?
|
| Weight Gain | 5 | 2021 | 401 | 0.930 |
Why?
|
| Chloride Channels | 1 | 2024 | 62 | 0.920 |
Why?
|
| Fasting | 4 | 2021 | 296 | 0.890 |
Why?
|
| Light | 1 | 2024 | 175 | 0.890 |
Why?
|
| Habenula | 1 | 2024 | 45 | 0.890 |
Why?
|
| Benzazepines | 2 | 2021 | 64 | 0.870 |
Why?
|
| Receptor, Melanocortin, Type 4 | 5 | 2023 | 28 | 0.860 |
Why?
|
| Memory | 2 | 2024 | 360 | 0.850 |
Why?
|
| Signal Transduction | 23 | 2021 | 4495 | 0.840 |
Why?
|
| Weight Loss | 4 | 2023 | 478 | 0.840 |
Why?
|
| Overnutrition | 2 | 2021 | 14 | 0.820 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 4 | 2024 | 20 | 0.810 |
Why?
|
| Neuronal Plasticity | 2 | 2024 | 274 | 0.810 |
Why?
|
| Nitric Oxide | 4 | 2007 | 432 | 0.800 |
Why?
|
| Diet, High-Fat | 13 | 2024 | 208 | 0.800 |
Why?
|
| Hypoglycemia | 1 | 2023 | 191 | 0.770 |
Why?
|
| Dopaminergic Neurons | 3 | 2023 | 49 | 0.770 |
Why?
|
| Male | 61 | 2024 | 60040 | 0.740 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2021 | 33 | 0.730 |
Why?
|
| Mesencephalon | 4 | 2022 | 42 | 0.710 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 231 | 0.700 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 37 | 0.700 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2021 | 201 | 0.700 |
Why?
|
| GABAergic Neurons | 7 | 2021 | 54 | 0.690 |
Why?
|
| Peptide Fragments | 8 | 2022 | 748 | 0.680 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2020 | 72 | 0.670 |
Why?
|
| Adrenomedullin | 5 | 2007 | 74 | 0.670 |
Why?
|
| Feeding and Eating Disorders | 2 | 2019 | 70 | 0.670 |
Why?
|
| Anhedonia | 1 | 2019 | 30 | 0.670 |
Why?
|
| Long-Term Potentiation | 1 | 2021 | 163 | 0.660 |
Why?
|
| Peptides | 4 | 2015 | 796 | 0.650 |
Why?
|
| Circadian Rhythm | 5 | 2021 | 269 | 0.620 |
Why?
|
| Pyrimidines | 1 | 2021 | 374 | 0.600 |
Why?
|
| Thermogenesis | 5 | 2020 | 44 | 0.600 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 2531 | 0.590 |
Why?
|
| Female | 42 | 2024 | 65444 | 0.580 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 766 | 0.560 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2016 | 13 | 0.550 |
Why?
|
| Adipose Tissue | 2 | 2021 | 465 | 0.540 |
Why?
|
| Receptors, Leptin | 4 | 2023 | 42 | 0.530 |
Why?
|
| Phosphoproteins | 1 | 2018 | 399 | 0.520 |
Why?
|
| Apolipoprotein A-V | 1 | 2015 | 20 | 0.510 |
Why?
|
| Receptors, GABA-A | 5 | 2023 | 59 | 0.510 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2015 | 26 | 0.510 |
Why?
|
| Amygdala | 1 | 2016 | 81 | 0.500 |
Why?
|
| Peptide Hormones | 3 | 2022 | 66 | 0.500 |
Why?
|
| Medulla Oblongata | 2 | 2006 | 22 | 0.500 |
Why?
|
| rap1 GTP-Binding Proteins | 3 | 2021 | 12 | 0.490 |
Why?
|
| Liver | 7 | 2021 | 1735 | 0.490 |
Why?
|
| Reproduction | 1 | 2016 | 243 | 0.470 |
Why?
|
| Stress, Psychological | 1 | 2019 | 557 | 0.470 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 126 | 0.460 |
Why?
|
| Hyperphagia | 5 | 2016 | 46 | 0.460 |
Why?
|
| gamma-Aminobutyric Acid | 5 | 2021 | 167 | 0.460 |
Why?
|
| Piperazines | 2 | 2015 | 231 | 0.460 |
Why?
|
| STAT3 Transcription Factor | 2 | 2016 | 216 | 0.460 |
Why?
|
| Disease Models, Animal | 10 | 2024 | 4269 | 0.450 |
Why?
|
| Trans-Activators | 1 | 2018 | 809 | 0.450 |
Why?
|
| Stress, Physiological | 1 | 2016 | 263 | 0.450 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2017 | 384 | 0.450 |
Why?
|
| Steroidogenic Factor 1 | 5 | 2021 | 31 | 0.440 |
Why?
|
| Serotonergic Neurons | 2 | 2024 | 21 | 0.420 |
Why?
|
| Insulin | 8 | 2021 | 1197 | 0.420 |
Why?
|
| Heart Rate | 2 | 2006 | 585 | 0.410 |
Why?
|
| Humans | 39 | 2024 | 123157 | 0.400 |
Why?
|
| Depression | 2 | 2021 | 1225 | 0.390 |
Why?
|
| Blood Pressure | 4 | 2016 | 1315 | 0.380 |
Why?
|
| Rats | 8 | 2024 | 3631 | 0.380 |
Why?
|
| Central Nervous System | 2 | 2016 | 253 | 0.380 |
Why?
|
| Nuclear Receptor Coactivator 1 | 3 | 2019 | 242 | 0.380 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2007 | 160 | 0.380 |
Why?
|
| Hyperglycemia | 4 | 2021 | 218 | 0.370 |
Why?
|
| Fenfluramine | 1 | 2010 | 11 | 0.370 |
Why?
|
| Calcium | 2 | 2007 | 1094 | 0.370 |
Why?
|
| Exercise | 1 | 2017 | 811 | 0.360 |
Why?
|
| Bicuculline | 2 | 2015 | 21 | 0.360 |
Why?
|
| Feedback, Physiological | 3 | 2021 | 69 | 0.360 |
Why?
|
| Appetite Regulation | 3 | 2017 | 41 | 0.360 |
Why?
|
| Preoptic Area | 2 | 2020 | 12 | 0.340 |
Why?
|
| Glutamic Acid | 4 | 2023 | 194 | 0.330 |
Why?
|
| TRPC Cation Channels | 2 | 2024 | 22 | 0.330 |
Why?
|
| Hypothalamic Area, Lateral | 3 | 2019 | 6 | 0.330 |
Why?
|
| Nerve Net | 2 | 2024 | 236 | 0.320 |
Why?
|
| Models, Biological | 4 | 2021 | 1442 | 0.320 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2020 | 514 | 0.320 |
Why?
|
| Adipocytes | 3 | 2021 | 158 | 0.320 |
Why?
|
| Appetite | 3 | 2021 | 34 | 0.310 |
Why?
|
| Diet | 1 | 2015 | 1125 | 0.300 |
Why?
|
| Membrane Proteins | 4 | 2024 | 1528 | 0.290 |
Why?
|
| Body Temperature | 2 | 2020 | 106 | 0.290 |
Why?
|
| Hypertension | 1 | 2016 | 1284 | 0.290 |
Why?
|
| ARNTL Transcription Factors | 2 | 2020 | 38 | 0.290 |
Why?
|
| Appetite Depressants | 5 | 2021 | 22 | 0.280 |
Why?
|
| Adipose Tissue, White | 2 | 2019 | 79 | 0.280 |
Why?
|
| Receptors, Ghrelin | 2 | 2017 | 28 | 0.270 |
Why?
|
| Fibrillin-1 | 3 | 2022 | 58 | 0.270 |
Why?
|
| Baroreflex | 1 | 2006 | 2 | 0.270 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2007 | 115 | 0.270 |
Why?
|
| Ovariectomy | 3 | 2021 | 181 | 0.260 |
Why?
|
| Sex Factors | 2 | 2021 | 1255 | 0.250 |
Why?
|
| Egtazic Acid | 1 | 2005 | 25 | 0.250 |
Why?
|
| Synaptic Transmission | 4 | 2021 | 348 | 0.240 |
Why?
|
| HEK293 Cells | 3 | 2022 | 740 | 0.240 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2021 | 1211 | 0.240 |
Why?
|
| Enkephalins | 1 | 2024 | 20 | 0.240 |
Why?
|
| Isothiuronium | 1 | 2004 | 1 | 0.240 |
Why?
|
| Darkness | 1 | 2024 | 29 | 0.240 |
Why?
|
| Ornithine | 1 | 2004 | 25 | 0.230 |
Why?
|
| Electrophysiology | 3 | 2020 | 268 | 0.230 |
Why?
|
| Protein Precursors | 1 | 2024 | 149 | 0.220 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2020 | 10 | 0.220 |
Why?
|
| Anoctamins | 1 | 2023 | 15 | 0.220 |
Why?
|
| Depression, Postpartum | 1 | 2024 | 50 | 0.220 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2024 | 72 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 2021 | 137 | 0.220 |
Why?
|
| Inflammation | 3 | 2020 | 1402 | 0.220 |
Why?
|
| Forkhead Box Protein O1 | 3 | 2018 | 95 | 0.220 |
Why?
|
| Tauopathies | 1 | 2024 | 56 | 0.220 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2023 | 5 | 0.210 |
Why?
|
| Mice, Obese | 3 | 2020 | 78 | 0.210 |
Why?
|
| Receptors, Calcitriol | 2 | 2021 | 70 | 0.210 |
Why?
|
| Models, Animal | 4 | 2021 | 464 | 0.210 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2021 | 165 | 0.200 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2022 | 6 | 0.200 |
Why?
|
| Energy Intake | 2 | 2018 | 487 | 0.200 |
Why?
|
| Body Temperature Regulation | 2 | 2020 | 30 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2021 | 792 | 0.200 |
Why?
|
| Phenylalanine | 1 | 2022 | 120 | 0.200 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2021 | 17 | 0.200 |
Why?
|
| Pleasure | 1 | 2021 | 12 | 0.200 |
Why?
|
| Satiety Response | 1 | 2021 | 32 | 0.200 |
Why?
|
| Protein Binding | 2 | 2024 | 1743 | 0.200 |
Why?
|
| Dioxoles | 1 | 2021 | 10 | 0.190 |
Why?
|
| Postprandial Period | 1 | 2021 | 77 | 0.190 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 2 | 2015 | 15 | 0.190 |
Why?
|
| Lipolysis | 1 | 2021 | 82 | 0.190 |
Why?
|
| Satiation | 1 | 2021 | 23 | 0.190 |
Why?
|
| Physical Conditioning, Animal | 1 | 2022 | 91 | 0.190 |
Why?
|
| Receptors, Adrenomedullin | 3 | 2006 | 16 | 0.190 |
Why?
|
| Neural Conduction | 1 | 2021 | 92 | 0.190 |
Why?
|
| Torpor | 1 | 2020 | 1 | 0.190 |
Why?
|
| Forkhead Transcription Factors | 2 | 2021 | 369 | 0.190 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2021 | 21 | 0.190 |
Why?
|
| Genes, fos | 1 | 2021 | 17 | 0.190 |
Why?
|
| Dietary Fats | 3 | 2013 | 296 | 0.190 |
Why?
|
| Time | 1 | 2021 | 94 | 0.190 |
Why?
|
| Staining and Labeling | 1 | 2021 | 183 | 0.180 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 62 | 0.180 |
Why?
|
| Gluconeogenesis | 2 | 2018 | 107 | 0.180 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2020 | 19 | 0.180 |
Why?
|
| Nitric Oxide Synthase | 3 | 2007 | 185 | 0.180 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 96 | 0.180 |
Why?
|
| Pituitary Hormone-Releasing Hormones | 1 | 2020 | 8 | 0.180 |
Why?
|
| Neurosecretory Systems | 1 | 2020 | 23 | 0.180 |
Why?
|
| Anxiety | 3 | 2021 | 956 | 0.180 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2015 | 94 | 0.180 |
Why?
|
| Growth Hormone | 2 | 2017 | 149 | 0.180 |
Why?
|
| Membrane Potentials | 3 | 2019 | 304 | 0.170 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 184 | 0.170 |
Why?
|
| Behavior | 1 | 2020 | 75 | 0.170 |
Why?
|
| Reperfusion Injury | 1 | 2021 | 102 | 0.170 |
Why?
|
| alpha-MSH | 2 | 2023 | 12 | 0.170 |
Why?
|
| Copper-transporting ATPases | 1 | 2020 | 25 | 0.170 |
Why?
|
| Calcitriol | 1 | 2020 | 79 | 0.170 |
Why?
|
| Eosinophils | 1 | 2021 | 121 | 0.170 |
Why?
|
| Brain Chemistry | 2 | 2021 | 120 | 0.170 |
Why?
|
| Growth Differentiation Factor 5 | 1 | 2019 | 3 | 0.170 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2020 | 33 | 0.170 |
Why?
|
| Vitamins | 1 | 2020 | 107 | 0.170 |
Why?
|
| Escape Reaction | 1 | 2019 | 15 | 0.170 |
Why?
|
| Collagen Type I | 1 | 2020 | 110 | 0.170 |
Why?
|
| Incretins | 1 | 2019 | 25 | 0.160 |
Why?
|
| Encephalitis | 1 | 2020 | 108 | 0.160 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 130 | 0.160 |
Why?
|
| Sex Chromosomes | 1 | 2019 | 34 | 0.160 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2019 | 15 | 0.160 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2019 | 37 | 0.160 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2019 | 129 | 0.160 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2019 | 54 | 0.160 |
Why?
|
| Cues | 1 | 2019 | 88 | 0.160 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2019 | 83 | 0.160 |
Why?
|
| Hippocampus | 1 | 2024 | 812 | 0.160 |
Why?
|
| Transcriptional Activation | 1 | 2020 | 481 | 0.150 |
Why?
|
| Neuregulin-1 | 1 | 2018 | 13 | 0.150 |
Why?
|
| Adipogenesis | 2 | 2019 | 76 | 0.150 |
Why?
|
| Environment | 1 | 2019 | 143 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2022 | 1225 | 0.150 |
Why?
|
| Phenols | 2 | 2015 | 58 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2024 | 1116 | 0.150 |
Why?
|
| Nucleotidyltransferases | 1 | 2017 | 45 | 0.150 |
Why?
|
| Compulsive Behavior | 1 | 2018 | 40 | 0.150 |
Why?
|
| Phosphorylation | 2 | 2015 | 1611 | 0.150 |
Why?
|
| Receptor, ErbB-2 | 1 | 2021 | 496 | 0.150 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 329 | 0.150 |
Why?
|
| Depressive Disorder | 1 | 2021 | 451 | 0.140 |
Why?
|
| Receptor, Insulin | 1 | 2017 | 67 | 0.140 |
Why?
|
| Endocrinology | 1 | 2020 | 139 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2018 | 769 | 0.140 |
Why?
|
| Enzyme Inhibitors | 3 | 2005 | 571 | 0.140 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2017 | 15 | 0.140 |
Why?
|
| Aging | 2 | 2021 | 1172 | 0.140 |
Why?
|
| Glutathione Transferase | 1 | 2017 | 153 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2848 | 0.140 |
Why?
|
| N-Methylaspartate | 1 | 2016 | 29 | 0.140 |
Why?
|
| Genetic Variation | 2 | 2020 | 1480 | 0.140 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 142 | 0.140 |
Why?
|
| Memory Disorders | 1 | 2019 | 235 | 0.130 |
Why?
|
| Fatty Liver | 1 | 2018 | 176 | 0.130 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 211 | 0.130 |
Why?
|
| Fluoxetine | 1 | 2016 | 43 | 0.130 |
Why?
|
| Corticosterone | 1 | 2016 | 60 | 0.130 |
Why?
|
| Ion Channel Gating | 1 | 2016 | 123 | 0.130 |
Why?
|
| Receptor Activity-Modifying Proteins | 2 | 2007 | 16 | 0.130 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 126 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type I | 2 | 2007 | 29 | 0.130 |
Why?
|
| Heparin | 1 | 2017 | 227 | 0.130 |
Why?
|
| Arginine | 1 | 2017 | 298 | 0.130 |
Why?
|
| Vascular Stiffness | 1 | 2016 | 75 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2016 | 64 | 0.130 |
Why?
|
| Electrophysiological Phenomena | 1 | 2015 | 65 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 276 | 0.130 |
Why?
|
| Tetrodotoxin | 1 | 2015 | 50 | 0.130 |
Why?
|
| GABA Agents | 1 | 2015 | 21 | 0.130 |
Why?
|
| Pyrazoles | 2 | 2015 | 303 | 0.130 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 105 | 0.130 |
Why?
|
| Sodium Channel Blockers | 1 | 2015 | 24 | 0.130 |
Why?
|
| Infusions, Intraventricular | 3 | 2021 | 12 | 0.130 |
Why?
|
| Microinjections | 2 | 2006 | 52 | 0.130 |
Why?
|
| Cyclic AMP | 2 | 2007 | 247 | 0.120 |
Why?
|
| Hormones | 1 | 2016 | 190 | 0.120 |
Why?
|
| Valine | 1 | 2015 | 105 | 0.120 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2015 | 68 | 0.120 |
Why?
|
| Neurotransmitter Agents | 1 | 2016 | 139 | 0.120 |
Why?
|
| Cells, Cultured | 4 | 2021 | 3047 | 0.120 |
Why?
|
| Random Allocation | 1 | 2016 | 423 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 1014 | 0.120 |
Why?
|
| Cell Separation | 1 | 2015 | 232 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2015 | 98 | 0.120 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 207 | 0.120 |
Why?
|
| Phloretin | 1 | 2014 | 2 | 0.120 |
Why?
|
| Alleles | 2 | 2019 | 1604 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2815 | 0.120 |
Why?
|
| Cell Line | 2 | 2020 | 2774 | 0.120 |
Why?
|
| Reference Values | 1 | 2016 | 696 | 0.120 |
Why?
|
| Genes, Reporter | 1 | 2015 | 384 | 0.120 |
Why?
|
| Vitamin D | 1 | 2016 | 157 | 0.120 |
Why?
|
| Receptors, Peptide | 2 | 2005 | 47 | 0.120 |
Why?
|
| Indazoles | 2 | 2004 | 23 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 394 | 0.120 |
Why?
|
| Peptides, Cyclic | 1 | 2014 | 52 | 0.120 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 966 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 568 | 0.110 |
Why?
|
| Blotting, Western | 1 | 2016 | 1101 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 1870 | 0.110 |
Why?
|
| Action Potentials | 1 | 2016 | 499 | 0.110 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 428 | 0.110 |
Why?
|
| Glucagon-Like Peptide 2 | 1 | 2013 | 54 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2007 | 554 | 0.100 |
Why?
|
| Drug Resistance | 2 | 2013 | 256 | 0.100 |
Why?
|
| Receptors, Melanocortin | 1 | 2011 | 3 | 0.100 |
Why?
|
| Gene Expression | 3 | 2021 | 1569 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 261 | 0.100 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 145 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1580 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1682 | 0.090 |
Why?
|
| Biomarkers | 1 | 2020 | 2942 | 0.090 |
Why?
|
| Models, Neurological | 1 | 2011 | 204 | 0.090 |
Why?
|
| Infertility, Female | 1 | 2011 | 165 | 0.090 |
Why?
|
| Optogenetics | 2 | 2021 | 48 | 0.090 |
Why?
|
| Brain Stem | 1 | 2010 | 115 | 0.090 |
Why?
|
| In Situ Hybridization | 2 | 2015 | 473 | 0.080 |
Why?
|
| Adiposity | 2 | 2022 | 191 | 0.080 |
Why?
|
| Grooming | 2 | 2019 | 8 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2486 | 0.080 |
Why?
|
| Pregnancy | 2 | 2021 | 7137 | 0.080 |
Why?
|
| Vesicular Inhibitory Amino Acid Transport Proteins | 2 | 2019 | 17 | 0.070 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 2 | 2019 | 19 | 0.070 |
Why?
|
| Mutation | 2 | 2024 | 5773 | 0.070 |
Why?
|
| Fertility | 1 | 2010 | 263 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 3277 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2013 | 796 | 0.070 |
Why?
|
| Receptors, Calcitonin | 1 | 2007 | 21 | 0.070 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2007 | 22 | 0.070 |
Why?
|
| Protein Phosphatase 1 | 1 | 2007 | 50 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1907 | 0.070 |
Why?
|
| Heart Failure | 1 | 2020 | 2125 | 0.070 |
Why?
|
| Behavior, Animal | 2 | 2019 | 477 | 0.070 |
Why?
|
| 3T3-L1 Cells | 2 | 2017 | 56 | 0.070 |
Why?
|
| Isoquinolines | 1 | 2006 | 40 | 0.070 |
Why?
|
| Glucose Tolerance Test | 2 | 2016 | 204 | 0.060 |
Why?
|
| Motor Activity | 1 | 2008 | 520 | 0.060 |
Why?
|
| Thapsigargin | 1 | 2005 | 22 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2016 | 382 | 0.060 |
Why?
|
| Chelating Agents | 1 | 2005 | 42 | 0.060 |
Why?
|
| Calcium Channels, L-Type | 1 | 2005 | 53 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2019 | 793 | 0.060 |
Why?
|
| NADPH Dehydrogenase | 1 | 2004 | 7 | 0.060 |
Why?
|
| Dizocilpine Maleate | 1 | 2004 | 15 | 0.060 |
Why?
|
| Stimulation, Chemical | 1 | 2004 | 64 | 0.060 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2004 | 58 | 0.060 |
Why?
|
| NADP | 1 | 2004 | 47 | 0.060 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2005 | 87 | 0.060 |
Why?
|
| Paralysis | 1 | 2024 | 35 | 0.060 |
Why?
|
| Sulfonamides | 1 | 2006 | 259 | 0.060 |
Why?
|
| Oxytocin | 1 | 2024 | 70 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2005 | 289 | 0.060 |
Why?
|
| Maternal Behavior | 1 | 2024 | 67 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 280 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 211 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2004 | 312 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2018 | 12116 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2004 | 148 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 1062 | 0.050 |
Why?
|
| Sodium | 1 | 2004 | 290 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 2 | 2015 | 277 | 0.050 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2005 | 232 | 0.050 |
Why?
|
| tau Proteins | 1 | 2024 | 189 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 522 | 0.050 |
Why?
|
| Serotonin Agents | 1 | 2021 | 14 | 0.050 |
Why?
|
| Phenotype | 2 | 2023 | 4221 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2022 | 140 | 0.050 |
Why?
|
| Mice, 129 Strain | 1 | 2021 | 98 | 0.050 |
Why?
|
| Adipose Tissue, Beige | 1 | 2021 | 3 | 0.050 |
Why?
|
| GATA3 Transcription Factor | 1 | 2021 | 39 | 0.050 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2021 | 12 | 0.050 |
Why?
|
| Photoperiod | 1 | 2021 | 20 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2021 | 49 | 0.050 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2021 | 105 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 490 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 94 | 0.050 |
Why?
|
| Rhombencephalon | 1 | 2021 | 45 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 111 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 1 | 2021 | 77 | 0.050 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 75 | 0.050 |
Why?
|
| Mice, Inbred ICR | 1 | 2021 | 147 | 0.050 |
Why?
|
| Potassium | 1 | 2021 | 278 | 0.040 |
Why?
|
| Interleukin-13 | 1 | 2021 | 96 | 0.040 |
Why?
|
| Ligands | 1 | 2022 | 533 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 191 | 0.040 |
Why?
|
| Hypothermia | 1 | 2020 | 54 | 0.040 |
Why?
|
| Temperature | 1 | 2021 | 306 | 0.040 |
Why?
|
| Circadian Clocks | 1 | 2021 | 59 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2021 | 229 | 0.040 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2020 | 58 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 350 | 0.040 |
Why?
|
| Rats, Long-Evans | 1 | 2020 | 95 | 0.040 |
Why?
|
| Neuroblastoma | 1 | 2005 | 509 | 0.040 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2019 | 11 | 0.040 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2019 | 6 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 237 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 227 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2022 | 462 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2021 | 340 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 601 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 815 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2019 | 161 | 0.040 |
Why?
|
| Avoidance Learning | 1 | 2019 | 56 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 122 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2018 | 312 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 876 | 0.040 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2018 | 26 | 0.040 |
Why?
|
| Half-Life | 1 | 2018 | 156 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 617 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 315 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 423 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 867 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 101 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2021 | 1338 | 0.040 |
Why?
|
| Metabolome | 1 | 2020 | 292 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 2017 | 89 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 70 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2018 | 225 | 0.040 |
Why?
|
| Heterozygote | 1 | 2019 | 672 | 0.030 |
Why?
|
| Benzene Derivatives | 1 | 2016 | 19 | 0.030 |
Why?
|
| Synapsins | 1 | 2016 | 6 | 0.030 |
Why?
|
| Sulfones | 1 | 2016 | 67 | 0.030 |
Why?
|
| Systems Integration | 1 | 2016 | 27 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2017 | 136 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 409 | 0.030 |
Why?
|
| Protein Transport | 1 | 2017 | 370 | 0.030 |
Why?
|
| Calorimetry, Indirect | 1 | 2016 | 60 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2016 | 36 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 121 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 340 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 664 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 298 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2016 | 162 | 0.030 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2015 | 25 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2016 | 161 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 2585 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2015 | 155 | 0.030 |
Why?
|
| Malnutrition | 1 | 2017 | 196 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 771 | 0.030 |
Why?
|
| Receptors, Vasopressin | 1 | 2014 | 11 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2014 | 49 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2014 | 29 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 847 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2014 | 58 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2014 | 136 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2014 | 91 | 0.030 |
Why?
|
| Time Factors | 1 | 2004 | 6204 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 2307 | 0.030 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2013 | 23 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1170 | 0.030 |
Why?
|
| Glucagon-Like Peptide-2 Receptor | 1 | 2013 | 11 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 908 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 2023 | 0.030 |
Why?
|
| Dietary Sucrose | 1 | 2013 | 41 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 206 | 0.030 |
Why?
|
| Receptors, Glucagon | 1 | 2013 | 29 | 0.030 |
Why?
|
| Glucagon | 1 | 2013 | 185 | 0.030 |
Why?
|
| Uncoupling Protein 2 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Hyperinsulinism | 1 | 2013 | 68 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1293 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2020 | 827 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 310 | 0.030 |
Why?
|
| Mitochondria | 1 | 2017 | 678 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1683 | 0.030 |
Why?
|
| Ion Channels | 1 | 2013 | 188 | 0.020 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2011 | 4 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2013 | 239 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 2019 | 1043 | 0.020 |
Why?
|
| Echocardiography | 1 | 2016 | 1059 | 0.020 |
Why?
|
| Swine | 1 | 2014 | 1154 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 25966 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5046 | 0.020 |
Why?
|
| Antioxidants | 1 | 2013 | 337 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 4704 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 477 | 0.020 |
Why?
|
| Integrases | 1 | 2010 | 161 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2010 | 173 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 6028 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 29034 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 1011 | 0.020 |
Why?
|
| Testosterone | 1 | 2010 | 462 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 8865 | 0.010 |
Why?
|
| Child | 1 | 2022 | 24225 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 19095 | 0.010 |
Why?
|